{
    "links": "https://www.ycombinator.com/companies/delee",
    "name": "Delee",
    "headline": "Blood testing device for early diagnosis of cancer and treatment\u00e2\u0080\u00a6",
    "batch": "W17",
    "description": "Delee is a medical device company that developed a blood-testing device for early diagnosis of cancer and treatment monitoring through the isolation and analysis of the circulating tumor cells.",
    "activity_status": "Active",
    "website": "http://www.delee.co",
    "founded_date": 2017.0,
    "team_size": 18.0,
    "location": "Monterrey, Mexico",
    "group_partner": null,
    "group_partner_yc": null,
    "company_linkedin": null,
    "company_twitter": null,
    "tags": "industry:medical-devices; industry:diagnostics",
    "founders": [
        {
            "name": "Liza Velarde, Founder",
            "description": "Co-Founder and acting CEO at Delee Corp. Velarde has been responsible for the development and execution of the company's strategic plans. Velarde's outstanding work has been highly regarded by international institutions such as Cartier Women's Initiative Awards and WeXchange (from the Inter-American Development Bank).  She also lead and supervised the development of the Zen FluidicsTM scientific line, a group of products that enables researchers to develop their own microfluidic applications.",
            "linkedin": "https://www.linkedin.com/in/lizavelarde/"
        },
        {
            "name": "Alejandro Abarca-Blanco, Founder",
            "description": null,
            "linkedin": "https://linkedin.com/in/alejandroabarca"
        },
        {
            "name": "Juan Felipe Yee De Le\u00c3\u00b3n, Founder",
            "description": null,
            "linkedin": "https://mx.linkedin.com/in/juan-felipe-yee-55107a5b"
        }
    ],
    "status": true,
    "generated_description": "**Delee: Revolutionizing Cancer Detection with Blood Testing Technology**\n\nFounded in 2017 and based in Monterrey, Mexico, Delee is a pioneering medical device company on a mission to transform early cancer diagnosis and treatment monitoring. They leverage cutting-edge technology to isolate and analyze circulating tumor cells (CTCs), enabling more timely and accurate cancer detection.\n\nAs part of Y Combinator's Batch W17, Delee's small-but-mighty team of 18 is well-placed to harness innovation in the diagnostics space. Their flagship products are the **CytoCatch\u2122 Isolation Platform** and the **CytoCatch\u2122 Imaging System**. These devices stand out for their fully automated processes, promising outstanding recovery rates\u2014over 97%\u2014when isolating CTCs from various cancer types, including prostate, breast, lung, and colorectal cancers.\n\n### Key Features\n- **CytoCatch\u2122 Isolation Platform**: This innovative device excels in the reliable and reproducible isolation of CTCs, completely removing human error from the equation. It\u2019s designed for high efficiency, making it an ideal solution for researchers and clinicians alike.\n  \n- **CytoCatch\u2122 Imaging System**: This platform employs sophisticated computer vision and machine learning algorithms to accurately classify isolated CTCs. It's fully customizable, allowing researchers to tweak the components to better suit their experiments.\n\nDelee aims to push the limits of cancer research by offering customizable antibody panels and compatibility with modern molecular biology techniques, including next-generation sequencing. They\u2019re not just isolating cells; they\u2019re enabling an entirely new frontier in understanding cancer at the genetic level. \n\nIn a landscape that's often bogged down by complexity, Delee sets itself apart with a clear vision: leveraging technology to tackle one of the most daunting challenges in healthcare\u2014cancer. For anyone interested in early cancer diagnosis or working at the intersection of technology and medicine, Delee is definitely a name to follow. \n\nTo learn more about their offerings, you can visit their website at [Delee.co](http://www.delee.co).",
    "logo": "https://bookface-images.s3.us-west-2.amazonaws.com/logos/1bc9864f6019b7350a1e942ffe380fb8552d3c88.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAKBB576US%2F20250221%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20250221T191116Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJHMEUCIFRjVxB%2FHxIJHUHkMazoRi02jYmaJVJGr3K7C9j9jiflAiEA6iszI4%2Fpn8hDzk7aMP6LlnqynbPgCG20CpdZqslTFdsq7gMI3P%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FARAAGgwwMDYyMDE4MTEwNzIiDNVC6v4lNMvTlUOjTyrCA7R4NjcD6pWk9Gjux5NdrMhwU67pNo%2F0JVDzkHcTjBsajnWXpXoyD3m%2FssX0rwYmnUDJB9VTgD%2FW2M8cWxeD93WFxLjs25juzzGj1%2BC1Ky9E0oNPwn5jGw%2BjokWylkxcouU18mjUtP8juH4uF9Xfmm%2FMAgvOPsNSAaYBQ%2BdA5Vwom66MCzynAPEJs6Nqxd5FqtgiiWFRhT5L9g%2FvfLTKqpdIg0XPF6s95lLCtwWDHST72Bn9JVH2zZmqjTgO2sao7Rg4M%2BPIRazg8JhbPoWk6xsB2yfG1f%2Bs8AFVxihyUnQj6TUnhrhezs7WYsaTfaaAoTIzhEsLwJDqBQDSptmSlUj%2BQ3KWwrXpJIm0b1uOmaylnrEpn5obECdRc%2FzdEfNt6DNEE5cbUhQo8Gjfd6MWfyV7JHtX7DwsLMssQPKNZ6qWJq2gP1fVHFkz5K0F%2F73p54AKB5gCkyOeRPJHmAzYMdfZpMF%2B8hE4eZU6k7m1EqPLEW2F9HVvcqPFp8T%2BZgbbDLBVWICSdX%2FfJ%2BniwyC72aHLaqjCxHLvJ6WyAawaepaDD9csEvz4DYD9lpHx9hJXqrFDyrT1vAaaBwuoXgulZ6gNmjCmiuO9BjqlATnnhPFnQUT7QmhXwrAFbGCqdgkRFIVCdDrNmasZJtz86frmIpB%2BlwZjavL0FMq46mN9RKFTuRNdMnOtOh1adMI%2BkC%2F%2Bs3m8pwR56JxErG%2B8nIBe7efeu5WiUZbGCsp85oXBCGY%2FoP1uWrJo843L0LVdmjtyXaDurxXSgzfeZo2RDONME7LNkPzuGzA19XefIc9OvA1QFcZr3VIdZe%2BLywfFgDpgwA%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=38c9ab508894e12b9d09f7d672b75665b783e92176dc9e30212da638f7b9d595",
    "social_links": [
        "https://www.linkedin.com/company/35691474",
        "https://twitter.com/deleecorp",
        "https://www.facebook.com/DeleeCorp/"
    ],
    "logo_path": "data/logos\\Delee_logo.png"
}